QuantalX Neuroscience has gained the European CE Medical Device Regulation (MDR) approval for the Delphi-MD, a device for ...

The changes strengthen Augere’s ability to focus on commercial activities and strategic objectives Augere Medical strengthens its management team Augere Medical Board of Directors OSLO, Norway, Feb.

Modular Medical develops patented insulin delivery technologies, aiming to improve access to glycemic control. Its founder, ...

QuantalX Neuroscience Ltd. is proud to announce that its groundbreaking brain health assessment device, the Delphi-MD, has ...

AI-Guided Cardiac Ablation in combination with pulmonary vein isolation was superior to the standard of care in the treatment of Persistent Atrial Fibrillation; Volta Medical Anno ...

The refurbished medical equipment market is rapidly gaining traction as an essential component of modern healthcare, ...

Once the CE mark is obtained, a device can be marketed and sold in Europe and ... SAN DIEGO, CALIFORNIA / ACCESS Newswire / January 30, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ('Modular Medical' or ...

Profound management will host a conference call at 4:30 p.m. ET to review the financial results and discuss business developments in the period. Fourth Quarter and Full Year 2024 Results Conference ...

Modular Medical currently believes that it will obtain the CE mark during the first quarter ... launch the next generation of insulin delivery technology. Using its patented technologies, the ...

Modular Medical currently believes that it will obtain the CE mark during the first quarter of 2026 ... (NASDAQ:MODD) is a development-stage medical device company that intends to launch the next ...